general-medicine
RECIST 1.1 — Response Evaluation in Solid Tumours
Standard radiological response criteria for solid tumour clinical trials and routine oncology (Eisenhauer 2009). Assesses change in sum of longest diameters (SLD) of up to 5 target lesions vs baseline, and new lesions or unequivocal progression of non-target lesions.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.